Abstract
In continuation of our efforts to study the solution structure and conformational dynamics of insulin by time-resolved fluorescence spectroscopy, we have synthesized and examined the biological activity of five insulin analogues in which selected naturally occurring residues in the A-chain have been replaced with the strongly fluorescent tryptophan residue. The potency of these analogues was evaluated in lipogenesis assays in isolated rat adipocytes, in receptor binding assays using rat liver plasma membranes, and in two cases, in receptor binding assays using adipocytes. [A3 Trp]insulin displays a potency of 3% in receptor binding assays in both liver membranes and in adipocytes, but only 0.06% in lipogenesis assays as compared to porcine insulin. [A10 Trp] insulin displays a potency ofca. 40% andca. 25% in rat liver receptor binding and lipogenesis assays, respectively. [A13 Trp]insulin displays a potency ofca. 39% in rat liver receptor binding assays, but onlyca. 9% in receptor binding in adipocytes; in lipogenesis assays, [A13 Trp] insulin displays a potency ofca. 12%, comparable to its potency in adipocyte receptor binding assays. [A15 Trp]insulin exhibits a potency of 18% and 9% in rat liver receptor binding and lipogenesis assays, respectively. The doubly substituted analogue, [A14 Trp, A19 Trp] insulin, displays a potency ofca. 0.7% in both rat liver receptor binding assays and lipogenesis assays. These data suggest two major conclusions: (1) the A3 and A15 residues lie in sensitive regions in the insulin molecule, and structural modifications at these positions have deleterious effects on biological activity of the hormone; and (2) [A13 Trp]insulin appears to be a unique case in which an insulin analogue exhibits a higher potency when assayed in liver tissue than when assayed in fat cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barany, G., and Merrifield, R. B. (1980). InThe Peptides Gross, E., and Meienhofer, J., eds.), Vol.2, Academic Press, New York, pp. 3–284.
Beechem, J. M., and Brand, L. (1985).Ann. Rev. Biochem. 54 43–71.
Blundell, T. L., Dodson, G. G., Dodson, E., Hodgkin, D. C., and Vijayan, M. (1971).Rec. Prog. Horm. Res. 27 1–40.
Blundell, T. L., Dodson, G. G., Hodgkin, D. C., and Mercola, D. (1972).Adv. Protein Chem. 26 279–402.
Burke, G. T., Chanley, J. D., Okada, Y., Cosmatos, A., Ferderigos, N., and Katsoyannis, P. G. (1980).Biochemistry 19 4547–4556.
Burke, G. T., Hu, S.-Q., Ohta, N., Schwartz, G. P., Zong, L., and Katsoyannis, P. G. (1990).Biochem. Biophys. Res. Commun. 173 982–987.
Chance, R. E., Hoffman, J. A., Kroeff, E.P., Johnson, M. G., Schirmer, E. W., Bromer, W. W., Ross, M. J., and Wetzel, R. (1981).Proc. Am. Pept. Symp. 7 721–728.
Chu, Y.-C., Zong, L., Burke, G. T., and Katsoyannis, P. G. (1992).J. Protein Chem. 11 571–577.
DiMarchi, R. D., Tam, J. P., Kent, S. B. H., and Merrifield, R. B. (1982).Int. J. Peptide Protein Res. 19 88–93.
Hagenmaier, H., and Frank, H. (1972).Hoppe-seyler's Z. Physiol. Chem. 353 1973–1976.
Hu, S.-Q, Burke, G. T. Schwartz, G. P., Ferderigos, N., and Katsoyannis, P. G. (1993).Biochemistry 32 2631–2635.
Joshi, S., Burke, G. T., and Katsoyannis, P. G. (1990).J. Protein Chem. 9 235–246.
Kaiser, E., Colescott, R. L., Bossinger, C. D., and Cook, P.I. (1970).Anal. Biochem. 34 595–598.
Katsoyannis P. G., Tometsko, A., Zalut, C., Johnson, S., and Trakatellis, A. C. (1967a).Biochemistry 6 2635–2641.
Katsoyannis, P. G., Trakatellis, A. C., Johnson, S., Zalut, C., and Schwartz, G.P. (1967b).Biochemistry 6 2642–2655.
Katsoyannis, P. G., Trakatellis, A. C., Zalut, C., Johnson, S., Tometsko, A., Schwartz, G. P., and Ginos, J. (1967c).Biochemistry 6 2656–2668.
King, G. L., and Kahn, C. R. (1981).Nature 292 644–646.
Kitagawa, K., Ogawa, H., Burke, G. T. Chanley, J. D., and Katsoyannis, P. G. (1984a).Biochemistry 23 1405–1413.
Kitagawa, K., Ogawa, H., Burke, G. T., Chanley, J. D., and Katsoyannis, P. G. (1984b).Biochemistry 23 4444–4448.
Kobayashi, M., Takata, Y., Ishibashi, O., Sasaoka, T., Iwasaki, M., Shigeta, Y., and Inouye, K. (1986).Biochem. Biophys. Res. Commun. 137 250–257.
Konev, S. V. (1967).Flourescence and Phosphoresence of Proteins and Nucleic Acids Plenum Press, New York.
Merrifield, R. B., Vizioli, L. D., and Boman, H. G. (1982).Biochemistry 21 5020–5031.
Murray-Rust, J., McLeod, A. N., Blundell, T. L., and Wood, S. P. (1992).BioEssays 14 325–331.
Ogawa, H., Burke, G. T., and Katsoyannis, P. G. (1984).J. Protein Chem. 3 327–348.
Ohta, N., Burke G. T., and Katsoyannis, P. G. (1988).J. Protein Chem. 7 55–65.
Okada, Y., Chanley, J. D., Burke, G. T., and Katsoyannis, P. G. (1981).Hoppe-Seylers Z. Physiol Chem. 362 629–638.
Orlowska, A., Witkowska, E., and Izdebski, J. (1987).Int. J. Peptide Protein Res. 30 141–144.
Ross, J. B. A., Wyssbrod, H. R., Porter, R. A., Schwartz, G. P. Michaels, C. A., and Laws, W. R. (1992).Biochemistry 31 1585–1594.
Schwartz, G. P., Burke, G. T., and Katsoyannis, P. G. (1981).Int. J. Peptide Protein Res. 17 243–255.
Smith, L. F. (1966).Am. J. Med. 40 662–666.
Tam, J. P. Heath, W. F., and Merrifield, R. B. (1983).J. Amer. Chem. Soc. 105 6442–6455.
Wang, S.-H., Hu, S.-Q., Burke, G. T., and Katsoyannis, P. G. (1991).J. Protein Chem. 10 313–324.
Wetlaufer, D. B. (1962).Adv. Protein Chem. 17 303–390.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chu, YC., Thompson Burke, G., Alexander Ross, J.B. et al. The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin. J Protein Chem 12, 499–505 (1993). https://doi.org/10.1007/BF01025051
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01025051